Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions
- PMID: 34194298
- PMCID: PMC8236824
- DOI: 10.3389/fnmol.2021.618171
Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions
Abstract
The pathogenesis of neurodegenerative diseases (NDDs) is complex and diverse. Over the decades, our understanding of NDD has been limited to pathological features. However, recent advances in gene sequencing have facilitated elucidation of NDD at a deeper level. Gene editing techniques have uncovered new genetic links to phenotypes, promoted the development of novel treatment strategies and equipped researchers with further means to construct effective cell and animal models. The current review describes the history of evolution of gene editing tools, with the aim of improving overall understanding of this technology, and focuses on the four most common NDD disorders to demonstrate the potential future applications and research directions of gene editing.
Keywords: Alzheimer’s disease; Huntington’s disease; Parkinson’s disease; amyotrophic lateral sclerosis; gene editing; neurodegenerative disease.
Copyright © 2021 Zhu, Zhang, Yang, Hao and Duan.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery.Front Pharmacol. 2021 Jul 14;12:713963. doi: 10.3389/fphar.2021.713963. eCollection 2021. Front Pharmacol. 2021. PMID: 34335276 Free PMC article. Review.
-
Long Noncoding RNAs in Neurodegenerative Diseases: Pathogenesis and Potential Implications as Clinical Biomarkers.Front Mol Neurosci. 2021 Aug 4;14:685143. doi: 10.3389/fnmol.2021.685143. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34421536 Free PMC article.
-
Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities.Neuroprotection. 2024 Sep;2(3):182-195. doi: 10.1002/nep3.56. Epub 2024 Sep 15. Neuroprotection. 2024. PMID: 39364217 Free PMC article.
-
microRNAs and Neurodegenerative Diseases.Adv Exp Med Biol. 2015;888:85-105. doi: 10.1007/978-3-319-22671-2_6. Adv Exp Med Biol. 2015. PMID: 26663180 Review.
-
Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases.Front Neurosci. 2024 Nov 19;18:1481983. doi: 10.3389/fnins.2024.1481983. eCollection 2024. Front Neurosci. 2024. PMID: 39628659 Free PMC article. Review.
Cited by
-
Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection.Int J Mol Sci. 2023 Jan 3;24(1):823. doi: 10.3390/ijms24010823. Int J Mol Sci. 2023. PMID: 36614266 Free PMC article. Review.
-
RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases.Int J Mol Sci. 2021 Oct 11;22(20):10958. doi: 10.3390/ijms222010958. Int J Mol Sci. 2021. PMID: 34681616 Free PMC article. Review.
-
Viral and cellular insulators promote sustained HSV vector-mediated transgene expression in brain.Mol Ther. 2025 Apr 2;33(4):1420-1433. doi: 10.1016/j.ymthe.2025.02.039. Epub 2025 Feb 28. Mol Ther. 2025. PMID: 40022446 Free PMC article.
-
Emerging Perspectives on Prime Editor Delivery to the Brain.Pharmaceuticals (Basel). 2024 Jun 11;17(6):763. doi: 10.3390/ph17060763. Pharmaceuticals (Basel). 2024. PMID: 38931430 Free PMC article. Review.
-
The Role of Oxidative Stress in Trisomy 21 Phenotype.Cell Mol Neurobiol. 2023 Nov;43(8):3943-3963. doi: 10.1007/s10571-023-01417-6. Epub 2023 Oct 11. Cell Mol Neurobiol. 2023. PMID: 37819608 Free PMC article. Review.
References
-
- Ababneh N. A., Scaber J., Flynn R., Douglas A., Barbagallo P., Candalija A., et al. (2020). Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair. Hum. Mol. Genet. 29 2200–2217. 10.1093/hmg/ddaa106 - DOI - PMC - PubMed
-
- Abo-Rady M., Kalmbach N., Pal A., Schludi C., Janosch A., Richter T., et al. (2020). Knocking out C9ORF72 exacerbates axonal trafficking defects associated with hexanucleotide repeat expansion and reduces levels of heat shock proteins. Stem Cell Rep. 14 390–405. 10.1016/j.stemcr.2020.01.010 - DOI - PMC - PubMed
-
- An M. C., O’Brien R. N., Zhang N., Patra B. N., De La Cruz M., Ray A., et al. (2014). Polyglutamine disease modeling: epitope based screen for homologous recombination using CRISPR/Cas9 system. PLoS Curr. 6:ecurrents.hd.0242d2e7ad72225efa72f6964589369a. 10.1371/currents.hd.0242d2e7ad72225efa72f6964589369a - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources